← All Investors
2SEVENTY BIO INC
TSVT*
Holders
0
Combined Value
$0
Combined Shares
0
Investor Activity
BUYSELLImplied priceClick a quarter to see who traded
Held By
| Investor | Value | % of Portfolio | Avg Buy Price | Gain | Last Activity | As of |
|---|
No tracked investors currently hold this security.
Recent Activity
| Quarter | Investor | Action | Est. Value | Est. Price |
|---|---|---|---|---|
| Q2 2025 | Israel Englander - Millennium Management | SOLD OUT | −$1.0M | ~$4.94 |
| Q2 2025 | Ken Griffin - Citadel Advisors | SOLD OUT | −$154K | ~$4.94 |
| Q2 2025 | Cliff Asness - AQR Capital | SOLD OUT | −$106K | ~$4.96 |
| Q1 2025 | Steve Cohen - Point72 | SOLD OUT | −$913K | ~$2.94 |
| Q1 2025 | Israel Englander - Millennium Management | BUY | +$807K | ~$4.94 |
| Q1 2025 | Cliff Asness - AQR Capital | NEW BUY | +$106K | ~$4.96 |
| Q1 2025 | Ken Griffin - Citadel Advisors | SELL | −$6.0K | ~$4.94 |
| Q4 2024 | Steve Cohen - Point72 | NEW BUY | +$913K | ~$2.94 |
| Q4 2024 | Israel Englander - Millennium Management | SELL | −$308K | ~$2.94 |
| Q4 2024 | Cliff Asness - AQR Capital | SOLD OUT | −$272K | ~$4.72 |
| Q4 2024 | Ken Griffin - Citadel Advisors | SELL | −$37K | ~$2.94 |
| Q3 2024 | Israel Englander - Millennium Management | SELL | −$1.5M | ~$4.72 |
| Q3 2024 | Cliff Asness - AQR Capital | SELL | −$493K | ~$4.72 |
| Q3 2024 | Ken Griffin - Citadel Advisors | BUY | +$26K | ~$4.72 |
| Q2 2024 | Israel Englander - Millennium Management | NEW BUY | +$1.8M | ~$3.85 |
| Q2 2024 | Cliff Asness - AQR Capital | NEW BUY | +$611K | ~$3.77 |
| Q2 2024 | Ken Griffin - Citadel Advisors | NEW BUY | +$153K | ~$3.85 |
Ownership History
| Period | Holders | Total Shares | Δ Shares | Total Value | Implied Price |
|---|---|---|---|---|---|
| Q1 2025 | 3 | 265,015 | −32.4% | $1.3M | $4.94 |
| Q4 2024 | 3 | 391,920 | +52.8% | $1.2M | $2.94 |
| Q3 2024 | 3 | 256,554 | −62.1% | $1.2M | $4.72 |
| Q2 2024 | 3 | 677,071 | — | $2.6M | $3.83 |